|
|
Article: University of Illinois at Chicago Grants License for Novel Drug Therapy for Sleep Apnea.
- Article from:
- AScribe Law News Service
- Article date:
- September 27, 2004
CopyrightCOPYRIGHT 2004 AScribe. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: University of Illinois at Chicago
CHICAGO, Sept. 27 (AScribe Newswire) -- A promising drug therapy for the treatment of sleep apnea, a serious and common sleep-related breathing disorder has been licensed by the University of Illinois at Chicago, where it was first conceptualized, to an intellectual property and technology commercialization company for clinical development.
UIC signed a licensing and research agreement to further develop a novel pharmacological therapy for sleep apnea with BTG, of Conshohocken, Pa.
The basis for the therapy was uncovered by two noted UIC sleep researchers, Drs. David Carley and Miodrag Radulovacki, who ...